| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.44▼ | 2.45▼ | 2.45▼ | 2.48▼ | 2.41▲ |
| MA10 | 2.41▲ | 2.41▲ | 2.40▲ | 2.42▲ | 2.57▼ |
| MA20 | 2.45▼ | 2.45▼ | 2.46▼ | 2.46▼ | 2.87▼ |
| MA50 | 2.47▼ | 2.48▼ | 2.51▼ | 2.71▼ | 2.89▼ |
| MA100 | 2.77▼ | 2.85▼ | 2.87▼ | 2.91▼ | 2.92▼ |
| MA200 | 2.98▼ | 2.99▼ | 2.94▼ | 2.95▼ | 8.31▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.009▲ | 0.012▲ | 0.019▲ | -0.071▼ |
| RSI | 47.956▼ | 48.058▼ | 47.565▼ | 47.541▼ | 44.172▼ |
| STOCH | 77.850 | 77.850 | 84.633▲ | 52.916 | 18.762▼ |
| WILL %R | -26.471 | -26.471 | -26.471 | -61.039 | -79.878▼ |
| CCI | 25.281 | 25.281 | 25.281 | -32.822 | -63.575 |
|
Tuesday, September 02, 2025 12:52 AM
We recently compiled a list of the 13 Best Psychedelic Stocks to Invest in Now. Cybin Inc. is one of them. Cybin Inc. (NYSE:CYBN) is a clinical-stage neuropsychiatry company developing ...
|
|
Saturday, March 15, 2025 05:00 PM
Guggenheim started coverage on shares of Cybin (NYSE:CYBN – Free Report) in a report published on Thursday, MarketBeat reports. The firm issued a buy rating and a $35.00 price target on the stock.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/09/25 | 2.415 | 2.46 | 2.415 | 2.43 | 15,487 |
| 12/09/25 | 2.55 | 2.55 | 2.40 | 2.46 | 24,300 |
| 11/09/25 | 2.48 | 2.55 | 2.4097 | 2.55 | 25,540 |
| 10/09/25 | 2.59 | 2.606 | 2.363 | 2.363 | 64,000 |
| 09/09/25 | 2.30 | 2.62 | 2.30 | 2.60 | 28,490 |
| 08/09/25 | 2.31 | 2.31 | 2.13 | 2.26 | 26,000 |
| 05/09/25 | 2.40 | 2.4303 | 2.16 | 2.2153 | 29,376 |
| 04/09/25 | 2.37 | 2.43 | 2.37 | 2.39 | 14,704 |
| 03/09/25 | 2.50 | 2.585 | 2.36 | 2.425 | 16,800 |
| 02/09/25 | 2.45 | 2.573 | 2.41 | 2.51 | 8,100 |
|
|
||||
|
|
||||
|
|